Immunomodulatory therapy to achieve maximum efficacy: Doses, monitoring, compliance, and self-infusion at home

Journal of Clinical Immunology

Volumn 30, Issue SUPPL. 1, 2010, Pages

  Lucas, Mary ^a   Hugh Jones, Ken ^a   Welby, Angela ^a   Misbah, Siraj ^a   Spaeth, Peter ^b   Chapel, Helen ^a,c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Chronic inflammatory demyelinating polyneuropathy; Intravenous immunoglobulin; Multifocal motor neuropathy; Subcutaneous immunoglobulin therapy

Indexed keywords

IMMUNOGLOBULIN; PREDNISOLONE; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTOR;

CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DISEASE CLASSIFICATION; DISEASE COURSE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG MEGADOSE; EPIDERMOLYSIS BULLOSA ACQUISITA; HOME MONITORING; HUMAN; IMMUNOCOMPETENCE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; MOTOR NEUROPATHY; MULTIFOCAL ACQUIRED DEMYELINATING SENSORY AND MOTOR NEUROPATHY; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; REVIEW; SELF MEDICATION; SEROLOGY; TREATMENT OUTCOME; ADOLESCENT; ADULT; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BLOOD; CASE REPORT; COMPLICATION; DRUG MONITORING; DRUG SELF ADMINISTRATION; FEMALE; FOLLOW UP; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; OUTPATIENT DEPARTMENT; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; PREGNANCY; PUERPERAL DISORDERS; RECURRENT DISEASE; SUBCUTANEOUS DRUG ADMINISTRATION; WALDENSTROM MACROGLOBULINEMIA;

ADOLESCENT; ADULT; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG MONITORING; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; OUTPATIENT CLINICS, HOSPITAL; PATIENT COMPLIANCE; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; PREGNANCY; PUERPERAL DISORDERS; RECURRENCE; SELF ADMINISTRATION; WALDENSTROM MACROGLOBULINEMIA;

EID: 77956190931     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-010-9400-y     Document Type: Review

References (14)

1. van Schaik IN, Winer J, de Hann R, Vemeulen M: Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst. Rev. 2002;(2):CD001797.
2. Nobile-Orazio E, Cappellari A, Priori A.Multifocal motor neuropathy: current concepts and controversies. Muscle Nerve. 2005;31(6):663-680
3. van Schaik IN, van den Berg LH, de Haan R, Vermeulen M: Intravenous immunoglobulin for multifocal motor neuropathy. Cochrane Database Syst. Rev. 2005;(2):CD004429.
4. Léger JM, Viala K, Cancalon F, Maisonobe T, Gruwez B, Waegemans T, et al. Intravenous immunoglobulin as short- and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients. J. Neurol. Neurosurg. Psychiatry. 2008;79(1):93-96
5. Sewell WA, Brennan VM, Donaghy M, Chapel HM. The use of self infused intravenous immunoglobulin home therapy in the treatment of acquired chronic demyelinating neuropathies. J. Neurol. Neurosurg. Psychiatry. 1997;63(1):106-109
6. Finsterer J. Treatment of immune-mediated, dysimmune neuropathies. Acta Neurol Scand. 2005;112(2):115-125
7. Tayal U, Burton J, Dash C, Wojnarowska F, Chapel H. Subcutaneous immunoglobulin therapy for immunomodulation in a patient with severe epidermolysis bullosa acquisita. Clin Immunol. 2008;129(3):518-519
8. Hughes RA. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial. Expert Rev Neurother. 2009;9(6):789-795
9. van der Pol W-L, Cats EA, van den Berg LH: Intravenous Immunoglobulin Treatment in Multifocal Motor Neuropathy. J Clin Immunol. 2010. doi:10.1007/s10875-010-9408-3.
10. Lucas M, et al: Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J. Allergy Clin. Immunol. In press.
11. Kyle RA, Benson J, Larson D, Therneau T, Dispenzieri A, Melton III LJ, et al. IgM monoclonal gammopathy of undetermined significance and smoldering Waldenstrom's macroglobulinemia. ClinLymphoma Myeloma. 2009;9(1):17-18
12. Eftimov F, Vermeulen M, de Haan RJ, van den Berg LH, Van Schaik. IN: Subcutaneous immunoglobulin therapy for multifocal motor neuropathy. J Peripher Nerv Syst. 2009;14(2):93-100.
13. Harbo T, Andersen H, Hess A, Hansen K, Sindrup SH, Jakobsen J. Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial. Eur J Neurol. 2009;16(5):631-638
14. Schleinitz N, Jean E, Benarous L, Mazodier K, Figarella-Branger D, Bernit E, et al. Subcutaneous immunoglobulin administration: an alternative to intravenous infusion as adjuvant treatment for dermatomyositis? Clin. Rheumatol. 2008;27(8):1067-1068